Post on 27-Mar-2015
ARHP
Management of Early Pregnancy Failures in the
Outpatient SettingEmily Godfrey MD MPH
Michelle Forcier MD MPHARHP National Conference 2006
Pre-Conference Workshop
ARHP
Objectives
• Appreciate the historical context regarding terminology, diagnosis, and management of early pregnancy failure and how it has evolved
• Recognize the various presentations and classifications of early pregnancy failure
• List new and different treatment options currently available for early pregnancy failure
• Describe new data suggesting a role for misoprostol in the management of early pregnancy failure
• Describe the current standard treatment using MVA for early pregnancy failure
ARHP
Early Pregnancy Failures
• Incidence:– 15-20% clinically recognized pregnancies– Estimated 30% if non-clinically recognized
pregnancies are included*
• 80% occur in first trimester
* Wilcox NEJM 1988
ARHP
Types of Early Pregnancy Failure• Threatened • Inevitable*
– Uterine cramping– Dilated cervical os
• Incomplete*– Inevitable with passage of some POCs
• Missed*– Closed os– Uterine cramping
• Septic• Complete
– No uterine cramping– Cervical os closed– Complete passage of tissue
* Early Pregnancy Failure
ARHP
History of the Management of EPF
• Pre 1880– Less is better
• Post 1880– Development of curette– Reduction of hemorrhage– Reduction of infection– Intervention advocated because high rates of
infection accompanying illegal abortion
ARHP
Management of EPF
• Today– D & C still remains the standard of care despite decreased incidence of
septic abortion– Potential complications
• Risk of anesthesia• Uterine perforation• Intrauterine adhesions• Cervical trauma• Pelvic Pain• Increased risk of ectopic pregnancy (subsequent)
• Alternative treatment options – Manual vacuum aspiration– Medical management with prostaglandin analogues (i.e. Misoprostol)* – Expectant management
ARHP
Expectant management
• In the setting of incomplete abortion expectant management is successful 82-96% of the time
• Average time to completion is 9 days• Success rate is less for embryonic death or
anembryonic gestations (missed abortions) (25-76%)• First trimester miscarriages may be expectantly
managed indefinitely if without hemorrhage or infections
Griebel AFP 2005
ARHP
Success of expectant management
Group N Complete day 7
Complete day 14
Success day 49
Incomplete 221 117 (53%) 185 (84%) 201 (91%)
Missed 138 41 (30%) 81 (59%) 105 (76%)
Anembryonic 92 23 (25%) 48 (52%) 61 (66%)
TOTAL 451 181 (40%) 314 (70%) 367 (81%)
Luise C. BMJ 2002
ARHP
Misoprostol (Cytotec)
• Prostaglandin E1• FDA approved for
prevention and treatment of gastric and duodenal ulcers
• Heat stable (does not need refrigeration)
• Inexpensive• Widely available• Oral preparation
– 100 g (non-scored) & 200 g (scored) tablets
ARHP
Misoprostol: Physiologic Effects
Uterine: Stimulate contractions
Cervical Softens and primes cervix
Gastrointestinal: Prevents/treats ulcersNauseaVomitingDiarrhea
Systemic: Fever
ARHP
Routes of Administration
Oral
Vaginal
Buccal
Sublingual
Rectal
ARHP
Vaginal Use
• Manufactured and approved for oral use only
• Greater effects on reproductive tract with vaginal dosing*
• Decreased gastrointestinal side effects with vaginal dosing*
*Danielsson 1999Creinin 1993
Toppozada 1997
ARHP
Buccal & Sublingual Use
• Mostly been studied with the use of induced medical abortion
• Sublingual has faster absorption than buccal*• Buccal as effective as vaginal in induced
medical abortion up to 56 days’ gestation• Sublingual as effective as vaginal misoprostol
in induced medical abortion up to 63 days’ gestation
*Schaff, EA et al. 2005*Tang, OS et al 2006
Middleton, T et al 2005
ARHP
Surgical options
• Sharp curettage (D and C) no longer an acceptable option due to higher complication rates
• Vacuum aspiration includes manual vacuum aspiration (MVA) vs. electrical pump aspiration
ARHP
MVA Instruments and Supplies
• Inexpensive• Small • Portable • Quiet• Specimen likely
to be intact• May require repeated reloading of suction
ARHP
Literature Review
• Standard dosage and dosing intervals have not been well established
• Studies difficult to compare– Various patient populations and dosing regimens– Different routes of administration– Varying definitions of success
ARHP
Incomplete and Missed AB
• Demetroulis et al, 2001• Prospective RCT• 80 women w/missed AB or incomplete AB• Misoprostol vs. Surgical evacuation • Results:
– 82.5% successful in Misoprostol group– Failure rate higher for Missed AB patients (23% v.
7%)
Demetroulis. Human Reproduction, 2001
ARHP
Missed Abortion
• Wood et al, 2002• Double blind randomized controlled trial (Type I
study)• 50 women
– Ultrasound dx of missed ab– Absence of cramping and bleeding– Less than 12 weeks uterine size
• 800 g misoprostol – up to 2 doses– Vaginal versus placebo
• Follow-up– 24 hours, 48 hours, 1 week
Wood and Brain, Obstet Gynecol 2002
ARHP
Missed Abortion
• Misoprostol– 15 of 25 completed after first dose @ 24h– 21 of 25 completed after second dose @ 48h– 2 had on-going bleeding– 1 had retained tissue
• Placebo– 1 of 25 completed after @ 48h– 4 of 25 completed @ 1 week
• No significant change in hemoglobin levels
Wood and Brain, Obstet Gynecol 2002
ARHP
Comparison of surgical with medical management: EPF
• Zhang et al, 2005• Prospective, RCT • 652 w/ 1st trimester pregnancy failure
– Anembryonic– Embyronic or fetal death– Incomplete– Inevitable
• Misoprostol 800 g, repeat day 3 – Vaginal versus surgical evacuation
• Complications– Surgical treatment for the miso group– Repeat surgical procedure within 30 days
Zhang. NEJM 2005
ARHP
Comparison of surgical with medical management: EPF
• Results– Misoprostol Group
• 71% complete by Day 3• 84% complete by Day 8
– Treatment Failure• 16% Misoprostol group• 3% Surgical group
• Conclusions– Treatment of EPF with Miso is safe and works about 84%
of the time
Zhang. NEJM 2005
ARHP
Missed Abortion Using Sublingual Misoprostol
• Tang, et al, 2006• Prospective randomized controlled trial • 180 women
– Ultrasound dx of missed ab – Absence of cramping and bleeding– Less than 13 weeks uterine size
• 600 g sublingual misoprostol Q 3 hours x 3 vs 400 g sublingual misoprostol daily x 1 week
• Results at 1 week– 92% completed in SL x 3 group– 93% complete in SL x 3 + daily group
• Greater side effects reported in the SL x 3 + daily group
Tang. Hum Reprod 2006
ARHP
Early Pregnancy Failure Treatment Using Mifepristone/Misoprostol
• Trinder, et al, 2006• Prospective randomized controlled trial • Miscarriage Treatment Trial (MIST)• 1200 women
– Less than 13 weeks gestation – Incomplete miscarriage, Anembryonic, Missed abortion
• Expectant vs. Medical vs. Surgical• Incomplete: 800 miso only vaginal• Anembyronic/Missed: 200 mife + 800 miso 24-48 hr• Primary outcome: infection within 14 days• Secondary outcome: efficacy (no D & C within 8 weeks)
Tinder. BMJ 2006
ARHP
Early Pregnancy Failure Treatment Using Mifepristone/Misoprostol
• Results– Gynecological Infection
• No difference between the groups– Anembyronic/Missed
• 6% Surgical group• 38% Medical group• 50% Expectant group
• Conclusions– Infection rates did not differ between groups– Surgical Management is more treatment option than
medical or expectant managementTinder. BMJ 2006
ARHP
Meta-analysis of Expectant, Surgical and Medical
• Comparison of expectant, medical and surgical treatment of 1st trimester spontaneous abortion
• 28 studies eligible for analysis
• Medical v. expectant: expectant was 39% successful.
• Medical 3 times more likely to be successful
Sotiriadis. Obstet Gynecol 2005
ARHP
• Surgical v. expectant: expectant was 79%• Surgical more likely to be successful than
expectant• Surgical v. medical: surgical was 1.5 times
more successful than medical• Pt satisfaction did not differ significantly
between surgical and medical, although trend favored medical management
Sotiriadis, Obstet Gynecol 2005
Meta-analysis of Expectant, Surgical and Medical, cont.
ARHP
Conclusion
• Early pregnancy failure is common • Expectant, medical and surgical management can
be done safely in an outpatient setting• Study findings vary because of lack of uniformity of
study populations• Patients should be counseled accordingly so they
can choose best treatment option
ARHP
CASES
Discussions about Outpatient Management of Miscarriage
ARHP
Case 1
You see a 18-year old woman, G2P1001, whose last period was 8 weeks ago. She had a positive home pregnancy test 3 weeks ago. Her first prenatal appointment is scheduled with another provider. She has not had an ultrasound during this pregnancy.
Three days ago, she began to spot. Today, her bleeding has increased, like a very heavy period with some clots. She began cramping last night and now reports that the cramping is severe. She comes to your clinic today for assessment and treatment if required.
ARHP
Case 1
Her medical history includes a spontaneous vaginal delivery 2002. She is otherwise healthy. On exam, she appears comfortable and is able to walk around the room and talk easily. Her vital signs:BP 110/70, Pulse 90, Temp 97.8
At this point, how would you proceed with evaluation?
ARHP
Case 1
The examination reveals the following– Abdomen: soft, nontender– Vaginal vault: scant amount of blood, consistent with a
menses– Cervix: os open, tissue at os noted – Bimanual exam: uterus enlarged, approx. 8 weeks size,
nontender
• Her hemoglobin is 12.2.• Urine pregnancy test: positive
What tests do you think you should order now?
ARHP
Case 1
The ultrasound reveals an intrauterine gestational sac, and thickened endometrial stripe.
What is the diagnosis?
What are the treatment options available for this patient?
ARHP
Case 1 Key ConceptsIncomplete/Inevitable Abortion
• 600-800 mcg effective dose without too many side effects
• May give vaginally, orally, sublingual (not well studied)
• May repeat
• More effective for incomplete abortions than for missed abortions
ARHP
Case 2
41 yo G1P1 presents to the Clinic for her first prenatal visit in a very desired pregnancy. Her LMP was 10 weeks ago and she is certain of her dates. The pregnancy has been uncomplicated except for a small amount a bleeding she had about 1 week ago. You evaluate the patient and finds that her BM exam is consistent with a 7 wk IUP, os is closed.
What other information might you be interested in knowing about? What might you order to get a diagnosis?
ARHP
Case 2
Fortunately, your Clinic has a portable ultrasound, and you are able to supervise the resident with a vaginal probe ultrasound. You see a well-circumscribed, though empty gestational sac.
What are your differential diagnoses? What do you tell the patient?
ARHP
Case 2
The patient returns 5 days later with further spotting and cramping. A 2nd serum β-hCG is done, as well as a repeat ultrasound. The ultrasound now shows a large irregular shaped gestational sac. The serum β-hCG level has dropped.
What is your assessment?
ARHP
Case 2
The patient decides to opt for medical treatment.
What regimen do you use?
How do you advise her? What can she expect?
ARHP
Case 2 Key ConceptsAnembryonic Pregnancy
• Consider the emotional aspects of miscarriage
• Element of choice in patient satisfaction
• Effectiveness of medication methods as well as surgical methods
ARHP
Case 3
26 yo G2P2002 LMP uncertain because of irregular periods well known to you presents to your office with spotting x 4 days. She denies any pain. Her urine pregnancy test is positive, her cervical os closed. Her uterus is retroverted. She has a remote history of Chlamydia infection about 10 years ago.
What is your differential diagnosis? What tests would you order now?
ARHP
Case 3
You perform an ultrasound and you see small echolucent area, which could be a small gestational sac or a pseudosac.
What should you do now?
What is your diagnosis? What are you options for treatment?
ARHP
Case 3 Key ConceptsEctopic Pregnancy
• Ectopic vs early pregnancy may be hard to differentiate
• Methotrexate an option for early & stable patients
• MVA can help evaluate POC in clinic, guiding diagnosis & referral decisions
ARHP
MVA for Miscarriage Management in the Out-Patient Setting
ARHP WorkshopSeptember 6, 2006
Emily Godfrey, MD MPHMichelle Forcier, MD MPH
ARHP
Updates in Miscarriage Management
• To discuss issues in evaluation & management of early miscarriage
• To discuss the evidence behind the options for miscarriage management
• To review manual vacuum aspiration (MVA) for miscarriage management– Summarize the safety and efficacy of MVA– Discuss pain management in out-patient settings– Discuss moving miscarriage management out of OR
• To demonstrate technique or update your skills in MVA for uterine evacuation
ARHP
What is MVA?
Goldberg 2004; Creinin 2001; Hemlin 2001
•Manual vacuum aspirator
•Semi-flexible plastic cannula
•Portable & reusable
•Efficacy = electric vacuum (98-99%)
ARHP
Indications for MVA
• Uterine evacuation first trimester– Induced abortion– Spontaneous abortion or early pregnancy
failure (EPF)
• Complications management– Incomplete medical abortion– Post-abortal hematometra
• Uterine sampling– Endometrial biopsy
ARHP
MVA Safety & Efficacy
• Hale 1979 (MVA in 1st trimester, gynecology office, Hawaii)• Edwards 1997 (MVA at < 6 weeks gestation, women’s clinic,
Texas)• Westfall 1998 (MVA in 1st trimester, family practice office,
Colorado)• Hemlin 2001 (EVA vs. MVA at < 8 weeks gestation, hospital
operating room, Sweden)• Paul 2002 (EVA and MVA at < 6 weeks, Planned Parenthood,
Massachusetts)• Goldberg 2004 (EVA vs. MVA up to 10 weeks, University of
California, San Francisco)
ARHP
Early Abortion with MVA
Author Date N Gestational Age
Efficacy
Paul et al. 2002 1,132 (MVA+EVA) <6 98%
Edwards & Carson
1997 1,530 MVA <6 99%
Edwards & Creinin
1997 2,399 MVA <6 99%
Hemlin & Moller 2001 91 MVA <8 98%
Laufe 1977 12,888 “About 6” 98%
Adapted from Baird and Flinn 2001
ARHP
MVA vs EVA
EVA
• Electric pump• Costly but longer life• Variable noise level• Not easily portable• Capacity: 350-1,200 cc• Constant suction• Fragmentation of POCs
MVA
• Manual aspirator• Inexpensive• Quiet• Portable• Capacity: 60 cc• Suction decreases as
aspirator fills• POCs likely intact
ARHP
Complications with MVA
• Rare
• Same as for EVA– Incomplete evacuation
– Uterine or cervical injury
– Infection
– Hemorrhage
– Vaso-vagal reaction
ARHP
MVA for Miscarriages
• Aspiration recommended if– Prolonged or excessive bleeding– Signs of infection– Patient preference
• Advantages– Portable & low cost device– Suitable for outpatient services– Applications to variety of settings (primary care,
ob/gyn office, ER)
ARHP
Patient Satisfaction
• Both EVA and MVA groups highly satisfied
• No difference reported in – Pain– Anxiety– Bleeding– Acceptability & satisfaction
• More EVA patients bothered by noise (p=0.03)
Bird et al. 2003, Dean et al. 2003, Edelman et al. 2001
ARHP
MVA Instruments
ARHP
MVA: Key Benefits• Safety & efficacy equivalent to EVA •Portable•Low tech•Low-cost•Small and quiet
Significant implications for incorporating services into the office settingDalton and Castleman 2002; Goldberg et al. 2004
ARHP
MVA: Essentials for Providers
• Pain management for awake patient
• Counseling & rapport
• Ultrasound
• Identifying products of conception
• Instrument processing
ARHP
Video of MVA Procedure
ARHP
MVA Video- Important Points?
ARHP
Video – Important Points
• Actual patient from local outpatient clinic
• Ibuprofen and paracervical block only
• In procedure room time ~10-15 minutes
• Actual time for uterine evacuation ~1-2 minutes
• Recovery time ~30 minutes
ARHP
Pain ManagementIn the
Out Patient Setting
ARHP
Pain Management in Outpatient Settings
• Staff often express concern that uterine evacuation requires general or conscious sedation
• Many uterine evacuations done under paracervical (local) block
• Definite ways you can improve pain management in your outpatient setting
ARHP
Pain Management Techniques
Local + IV 32%
General or nitrous 10%
Local 58%
With Addition Of:
•Focused breathing: 76%•Visualization: 31%•Localized massage: 14%
Lichtenberg 2001
ARHP
Importance of Pain Management
• Most common concern expressed by patient• Highly linked to patient satisfaction• Whose perspective?
– Patients– Clinician– Counselor/bedside assistant
• What are we trying to do?– Minimize risk / maximize benefit– Take away all pain/all feeling– Get through it
ARHP
Effective pain management
• What worsens pain?– Pre-procedure fearfulness– Anxiety– Depression
• What reduces pain?– Respectful, informed and supportive staff– Warm and friendly environment– Gentle operative technique– Women’s involvement & sense of control– Effective pain medications
Belanger 1989; Smith 1979
ARHP
Other Influences on Pain
• Provider– The clinician has a profound effect on pain score,
independent of anesthetic (Rawling 1998 and 2001)
• Patient’s sense of control– “The idea that I could manage the miscarriage
myself with guidance available whenever I needed it…I felt calmer, more confident, less medicated and out of control.”(Wiebe 1999)
ARHP
Role Play- Patient Centered Care
• 23 yro G1P0 miscarrying at EGA 8 weeks
• Very desired pregnancy
• Bleeding and cramping x 24 hrs
• No fetal heart activity & CRL only measuring 5 weeks
ARHP
Paracervical Block
Maltzer 1999; Castleman 2002
ARHP
Options for Anesthesia
• Local• Conscious sedation• Other
– Psychological
• Information, preparation & support – Music as analgesia
• 85% abortion patients wearing headphones rated pain as “0” compared to 52% controls
– DistractionStubblefield 1989
Shapiro 1974
ARHP
Curettage and Pain
• Using the curette often requires increased dilatation
• Curetting hurts! Makes reducing anesthesia more difficult
Sharp curettage generally not indicated & not routinely recommended following MVA
Forna 2002
ARHP
In Conclusion . . .
• No pain panacea– Affirm the patient’s existing viewpoint wherever possible– Avoid glib reassurances– Advise the patient that her fears are widely shared– Help the patient to differentiate between emotional and
physical pain
• Women want to be involved in developing their pain management plan
• Curette check hurts - usually not needed
• Pre-procedure preparation & psychological support reduce anxiety & improve overall experience
ARHP
Other Clinical Benefits of MVA
POCS are easier to visualize & inspect
– Often more intact
– Easier detection of early EGA • Fewer re-aspirations in MVA vs EVA group
(Goldberg 2004)
– Can still send to pathology for genetics
Goldberg 2004; MacIsaac 2000; Edwards 1997
ARHP
MVA POC Check: Benefits for EPL
Creinin and Edwards 1997
Electric Suction Machine MVA Aspirator
What is that?
There it is!
ARHP
MOVING OUT OF THE OPERATING ROOM
ARHP
Uterine evacuation- Why the OR?
• OR was necessary when emptying the uterus was an emergency– Abortion was illegal – Antibiotics were not available– Access to blood transfusion limited
“Puerperal (childbed) fever was the scourge of nineteenth century obstetrics and abortion.” Joffe 1999
• Today, out patient care safe, convenient, cost effective option for stable patients
ARHP
OR to Out Patient Clinic – Benefits
• Simplify scheduling• Reduce waiting and repeat exams
• Avoid cumbersome OR protocols • Prolonged NPO requirements & discharge criteria
• Save resources• Outpatient saves materials required,
costs/charges, personnel
Demetroulis 2001
ARHP
Out Patient - Benefits to your Patients
Why some patients want MVA
• Control/autonomy while awake during procedure• Convenience & time
– Single appointment – Rapid recovery time
• Personalized care by single provider• Improved patient education, attitudes,
accommodations in out patient setting (Lee 1996)
ARHP
Moving Miscarriage Management to Outpatient Setting – Johns Hopkins Study
Results
– Decreased anesthesia requirements– Decreased overall hospital stay from 19 to 6 hours– Decreased patient waiting time by 52%– Decreased procedure time from 33 to19 minutes– Decreased costs per case
$1404 in OR$827 in L&D$200 or less in ER
Blumenthal 1994
ARHP
Moving Abortion to an Outpatient Clinic - Bellevue Hospital
Methods• Compared costs, staff, complications: OR vs. Outpatient• N = 967; Patients undergoing first trimester pregnancy
termination in outpatient procedure room (2000-2002)
Results
Bellevue Hospital Improvement Reports, Masch 2002
Outpatient MVA
Operating
Room
Cost per Procedure
$167 $1,435
Staff 2 5
No reported complications with outpatient MVA
$1268 savings
ARHP
Moving Abortion to an Outpatient Clinic- University of Michigan
Results: 60 women chose clinic, 29 women chose OR
MVA: 91% would choose again
• “get home soon,” “avoid GA”
• 69% less patient time
• 50% shorter procedure time
Dalton 2003
Cost savings of moving out of the OR of $3,000 per case
ARHP
Medications/Supplies Needed
• Analgesia• Anesthetic• Silver nitrate or ferric
subsulfate• Uterotonic agent• Rhogam
• Urine pregnancy tests• Emergency cart• Pharmacologic agents
for cervical ripening (optional)
ARHP
Equipment Needed
PROCEDURE• Aspirators• Cannulae• Speculae• Sharp-toothed and/or
atraumatic tenaculae• Antiseptic solution• Mechanical dilators• 20-cc syringe for local
anesthesia
TISSUE EXAMINATION• Basin for POC• Fine-mesh kitchen
strainer• Back light• Tools to grasp tissue
and POC• Specimen containers
ARHP
Finances Behind Out Patient Tx
• Diagnosis code: 637.9 (Spontaneous Abortion, without mention of complication)
• CPT Billing codes for in office management vs in patient management– 59812 – Treatment of incomplete abortion, any trimester,
completed surgically– 59820 – Treatment of missed abortion, completed
surgically, first trimester
• Reimbursement issues
ARHP
Conclusions
Evidence demonstrates
• Uterine evacuation can be managed safely in an out-patient clinic setting
• Moving out of the operating room – Saves both time, money, resources– Offers significant both choice & advantages to
both women & clinicians
ARHP“Never, ever, think outside the box.”
ARHP
CASES
Discussions about MVA
For Outpatient Management of Miscarriage
ARHP
Case 1 continued
The same 18 yro G2P1001, experiencing mild-moderate cramping with mild-moderate bleeding in your clinic, and an ultrasound evidence of an incomplete abortion elects an MVA procedure as she wants to take care of this as soon as possible.
You are performing the MVA-all seems to be going well. However, the aspirator is only about one-quarter full and you remember from this course that at this gestational age, you would expect more tissue than this. You are not sure whether or not you are done.
ARHP
Case 1 continued
How can you tell if you are done? List 4 signs suggesting completion.
What do you do?
For “bonus” credit---at what pregnancy age does the volume of POC become more than 60 cc (equivalent to the volume of the aspirator)?
ARHP
MVA Key Concepts
• MVA safe & effective for early pregnancy loss in first trimester
• Allows for care that day, in the office, with their primary provider
• Any uterine evacuation’s efficacy is improved by systematically checking for completion
ARHP
Case 2 continued
41 yo G2P1001 with an LMP suggesting a 10 week pregnancy but ultrasound findings revealing anembryonic pregnancy. The patient decided to opt for medical treatment.
She took both mifepristone and misoprostol and is now seeing you for her routine follow-up visit, scheduled 2 weeks after she took mifepristone. She has been having persistent spotting, and says that she is really “sick of it.” Vaginal ultrasound reveals a non-viable, persistent gestational sac. Specifically, there is no evidence of growth but the sac is still present.
ARHP
Case 2 continued
You counsel her about options, including observation, repeating misoprostol, and surgical completion. The woman has significant childcare problems and wants to minimize the number of visits she must make to your clinic. Therefore, she requests surgical completion.
ARHP
Case 2 continued
You perform MVA and are partway through the aspiration when you note that the cannula seems to be sliding back and forth over the uterine lining too easily; it feels like nothing is happening.
What could be going on?What do you do to test your answer to question #1?How might MVA on this patient be different from
that performed on surgical abortion patients who have not received mifepristone or misoprostol?
ARHP
MVA Key Concepts
• Helpful to trouble shoot & know how to solve common MVA problems
• Lack of suction can caused by– Device not assembled or working properly– Clogged cannula
• Can never go wrong by stopping & reassessing
ARHP
Case 3 continued
26 yo G2P2002 LMP uncertain because of irregular periods is at your office for pregnancy termination with either early intrauterine versus ectopic pregnancy in the differential. She would like to deal with it today and with you if possible. You want to make sure it is not an ectopic pregnancy….
ARHP
Case 3 continued
Initially, dilitation of the cervix seems slightly more difficult than usual. However, after the first two dilator passes, it then progresses uneventfully. A 6 mm cannula is placed in the os, the aspirator is connected, and only scant blood is obtained. Dilitation for correct placement is attempted again. Again, only scant blood is obtained.
What do you think is happening?What do you do now?
ARHP
MVA Key Concepts
• Checking device & placement helpful when not getting scant or no products back
• Ultrasound helps assess placement of cannula
• MVA can be help diagnose ectopic pregnancy
• Floating products of conception very helpful in assessing uterine contents (and is easy to do)